Picture of TiumBio Co logo

321550 TiumBio Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for TiumBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsARSAnnual Audited AccountsAnnual Audited AccountsARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-32,253-31,402-19,038-23,546-18,787
Depreciation
Amortisation
Non-Cash Items3,22612,456-5,7074,9952,829
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital2,281-538875-875-3,022
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-24,802-16,013-20,616-15,628-15,303
Capital Expenditures-11,889-11,321-18,361-1,045-382
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-12,90235,7138,73025,7265,437
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-24,79224,392-9,63224,6815,055
Financing Cash Flow Items3,011-0.928-97.31,9920.711
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities53,0202,78422,979-2,7535,079
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3,41711,250-7,6215,945-5,692